A pioneering US biotech company developing pharmaceutical cannabis products, is pleased announce its plans to launch an online cannabis patient tracking system, which will be made available worldwide for private and secure usage and results tracking. This new initiative is based on the large amount of new inquiries from patients, relatives, and friends from all over the world; all inquiring about treatments for various critical ailments the Company has been focused on for Cannabis Science’s proprietary medical cannabis delivery methods and formulations.
The Company is in the process of creating a new section on its website to allow all Company approved users can track their usage and provide valuable patient input, and medical documentation regarding their experiences with medical marijuana and cannabis extracts. This data will go hand in hand with our licensed product development partners and their patients who wish to use it all adding to the cumulative international research and present critical patient data so that other patients may make informed decisions regarding their health care treatment options while furthering our studies and product development.
Dr. Robert Melamede, Ph. D., Cannabis Science Inc., President & CEO said, “We feel it is essential that CBIS work with patients around the world to foster policy changes that will increase the demand and availability of our products, in line with our expanding business opportunities that are developing through new partnerships and license agreements to maximize market potential for the Company and shareholders.”
via : Buisness Wire
You must be logged in to post a comment.